Equity Method Investment - Summary of Income Statement Information (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Schedule of Equity Method Investments [Line Items]
Net income (loss)	$ (62,293)	$ (27,029)	$ (41,307)
Share of loss from investments accounted for using the equity method	(3,197)	(5,284)	(10,005)
Angel Pharmaceuticals, Ltd
Schedule of Equity Method Investments [Line Items]
Revenue	0	0	0
Gross profit	0	0	0
Net income (loss)	(3,783)	(6,213)	(11,846)
Angel Pharmaceuticals, Ltd
Schedule of Equity Method Investments [Line Items]
Share of loss from investments accounted for using the equity method	$ (3,197)	$ (5,284)	$ (10,005)